Realcan Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 69.6% in First Quarter of 2023

Realcan Pharmaceutical Group Co.,Ltd. (瑞康医药集团股份有限公司) (002589.SZ) reported a net profit of 30 million yuan in the first quarter of 2023, down 69.6% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, down 49.4% year-on-year.

At the end of the reporting period, it had 19.2 billion yuan in total assets and 13.4 billion yuan in total liabilities, with a liability-to-asset ratio of 69.8%.